These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 23842123)

  • 21. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor.
    Weissman D; Rabin RL; Arthos J; Rubbert A; Dybul M; Swofford R; Venkatesan S; Farber JM; Fauci AS
    Nature; 1997 Oct; 389(6654):981-5. PubMed ID: 9353123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis.
    Yao Q; Compans RW; Chen C
    Virology; 2001 Jun; 285(1):128-37. PubMed ID: 11414813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted infection of HIV-1 Env expressing cells by HIV(CD4/CXCR4) vectors reveals a potential new rationale for HIV-1 mediated down-modulation of CD4.
    Ye Z; Harmison GG; Ragheb JA; Schubert M
    Retrovirology; 2005 Dec; 2():80. PubMed ID: 16371160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 envelope glycoprotein stimulates viral transcription and increases the infectivity of the progeny virus through the manipulation of cellular machinery.
    Ran X; Ao Z; Trajtman A; Xu W; Kobinger G; Keynan Y; Yao X
    Sci Rep; 2017 Aug; 7(1):9487. PubMed ID: 28842659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques.
    Pauza CD; Trivedi P; Wallace M; Ruckwardt TJ; Le Buanec H; Lu W; Bizzini B; Burny A; Zagury D; Gallo RC
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3515-9. PubMed ID: 10725402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Putative role of Tat-Env interaction in HIV infection.
    Poon S; Moscoso CG; Xing L; Kan E; Sun Y; Kolatkar PR; Vahlne AG; Srivastava IK; Barnett SW; Cheng RH
    AIDS; 2013 Sep; 27(15):2345-54. PubMed ID: 23835500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human immunodeficiency virus type 1-mediated syncytium formation is compatible with adenovirus replication and facilitates efficient dispersion of viral gene products and de novo-synthesized virus particles.
    Li H; Haviv YS; Derdeyn CA; Lam J; Coolidge C; Hunter E; Curiel DT; Blackwell JL
    Hum Gene Ther; 2001 Dec; 12(18):2155-65. PubMed ID: 11779400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization.
    Ince WL; Harrington PR; Schnell GL; Patel-Chhabra M; Burch CL; Menezes P; Price RW; Eron JJ; Swanstrom RI
    J Virol; 2009 May; 83(9):4068-80. PubMed ID: 19211740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of human immunodeficiency virus type 1 Env-mediated fusion by DC-SIGN.
    Nobile C; Moris A; Porrot F; Sol-Foulon N; Schwartz O
    J Virol; 2003 May; 77(9):5313-23. PubMed ID: 12692233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody to HIV-1 Tat protein inhibits the replication of virus in culture.
    Steinaa L; Sørensen AM; Nielsen JO; Hansen JE
    Arch Virol; 1994; 139(3-4):263-71. PubMed ID: 7832634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of antibody to HIV-1 Tat protein on viral replication in vitro and progression of HIV-1 disease in vivo.
    Re MC; Furlini G; Vignoli M; Ramazzotti E; Roderigo G; De Rosa V; Zauli G; Lolli S; Capitani S; La Placa M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):408-16. PubMed ID: 7583436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV type 1 Tat protein induces immunoglobulin and interleukin 6 synthesis by uninfected peripheral blood mononuclear cells.
    Rautonen J; Rautonen N; Martin NL; Wara DW
    AIDS Res Hum Retroviruses; 1994 Jul; 10(7):781-5. PubMed ID: 7986583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics.
    Lassen KG; Lobritz MA; Bailey JR; Johnston S; Nguyen S; Lee B; Chou T; Siliciano RF; Markowitz M; Arts EJ
    PLoS Pathog; 2009 Apr; 5(4):e1000377. PubMed ID: 19360131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-free infectivity of HIV type 1 produced in nonpermissive cells is only moderately impacted by C-terminal Env truncation despite abrogation of viral spread.
    Holtkotte D; Pfeiffer T; Bosch V
    AIDS Res Hum Retroviruses; 2007 May; 23(5):729-40. PubMed ID: 17531000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiretroviral therapy does not block the secretion of the human immunodeficiency virus tat protein.
    Mediouni S; Darque A; Baillat G; Ravaux I; Dhiver C; Tissot-Dupont H; Mokhtari M; Moreau H; Tamalet C; Brunet C; Paul P; Dignat-George F; Stein A; Brouqui P; Spector SA; Campbell GR; Loret EP
    Infect Disord Drug Targets; 2012 Feb; 12(1):81-6. PubMed ID: 22280310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of Non Canonical HIV-1 Tat Secretion Through the Cellular Na
    Agostini S; Ali H; Vardabasso C; Fittipaldi A; Tasciotti E; Cereseto A; Bugatti A; Rusnati M; Lusic M; Giacca M
    EBioMedicine; 2017 Jul; 21():170-181. PubMed ID: 28645727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restoration of cell surface CD4 expression in human immunodeficiency virus type 1-infected cells by treatment with a Tat antagonist.
    Shahabuddin M; Volsky B; Hsu MC; Volsky DJ
    J Virol; 1992 Nov; 66(11):6802-5. PubMed ID: 1404619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of HIV-1 infectivity through an innate mechanism involving naturally occurring IgM anti-leukocyte autoantibodies.
    Lobo PI; Schlegel KH; Yuan W; Townsend GC; White JA
    J Immunol; 2008 Feb; 180(3):1769-79. PubMed ID: 18209074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pertussis toxin enhances human immunodeficiency virus type 1 replication.
    Momoi Y; Ichiyama K; Chowdhury IH; Koyanagi Y; Yamamoto N
    AIDS Res Hum Retroviruses; 2000 Mar; 16(4):373-9. PubMed ID: 10716375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1 infection of the female reproductive tract.
    Howell AL; Asin SN; Yeaman GR; Wira CR
    Curr HIV/AIDS Rep; 2005 Feb; 2(1):35-8. PubMed ID: 16091247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.